Cynthia Chambers, MD
Dermatology · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
- Since medical school
- 15 years
- University of California, Davis School of Medicine, 2011
Offices
1 location · Pacific Skin Institute · 9 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chambers’s office at (916) 925-7020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
California Medical Board record
Licence A122534 · Current
Licensed to practise in California · since 2012 · expires 2028-06-30 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Dermatology - Dermatology
Original Medicare doctor bills
$199,938
Medicare paid this office $199,938 for 585 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 69 | $66,816 | $104 |
| Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | 16 | $29,870 | $117 |
| Short return visit (20+ min) | 290 | $24,210 | $65 |
| Return visit (30+ min) | 136 | $15,952 | $101 |
| Destruction of skin growth, 1-14 growths | 129 | $15,020 | $93 |
See all 16 services
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 69 | $66,816 | $104 |
| Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | 16 | $29,870 | $117 |
| Short return visit (20+ min) | 290 | $24,210 | $65 |
| Return visit (30+ min) | 136 | $15,952 | $101 |
| Destruction of skin growth, 1-14 growths | 129 | $15,020 | $93 |
| Destruction of precancer skin growth, 1 growth | 174 | $9,244 | $41 |
| Biopsy of related skin growth, first growth | 100 | $8,200 | $75 |
| New patient visit (30+ min) | 97 | $6,914 | $71 |
| New patient visit (45+ min) | 50 | $6,073 | $121 |
| Destruction of precancer skin growth, 2-14 growths | 131 | $4,538 | $6 |
| Destruction of precancer skin growth, 15 or more growths | 17 | $2,612 | $131 |
| Biopsy of related skin growth, each additional growth | 28 | $1,625 | $43 |
| Short return visit | 29 | $1,537 | $47 |
| Punch biopsy, first skin growth | 16 | $1,394 | $87 |
| Injection into skin growth, 1-7 growths | 14 | $843 | $42 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 24 | $84 | None |
Procedures Medicare counted
| Removal of skin lesions | 757 | More than 91% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 253 | More than 88% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 363 | 1,309 | 979 | 947 | 719 | 791 |
| Destruction of precancer skin growth, 1 growth | 91 | 327 | 295 | 286 | 201 | 224 |
| Destruction of skin growth, 1-14 growths | 64 | 149 | 204 | 190 | 126 | 162 |
| Biopsy of related skin growth, first growth | 54 | 182 | 155 | 152 | 95 | 110 |
| Biopsy of related skin growth, each additional growth | 27 | 152 | 86 | 87 | 56 | 38 |
| Punch biopsy, first skin growth | 31 | 128 | 74 | 78 | 25 | 16 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
585 Original Medicare patients in 2024. Average age 71 · Under 65 12% · 85 and older 9% · Women 59% · Also on Medicaid 42% · Health risk score 1.10. Above the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 68% · Diabetes 28% · Chronic kidney disease 21% · Coronary heart disease 19% · Depression 18% · Atrial fibrillation 15% · Cancer 12% · COPD 12% · Heart failure 11% · Stroke 6% · Dementia 5%.
The office billed $472,348, Medicare allowed $268,756 and paid $199,938; for 3,155 services of 27 kinds; $84 of it was for drugs given in the office and $199,855 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 585 | 3,155 | 71 | 1.10 | $472,348 | $199,938 |
| 2023 | 500 | 2,700 | 71 | 1.01 | $374,934 | $168,378 |
| 2022 | 732 | 3,839 | 71 | 1.07 | $524,293 | $229,098 |
| 2021 | 797 | 4,708 | 69 | 1.07 | $732,871 | $340,942 |
| 2020 | 783 | 5,205 | 68 | 1.18 | $690,143 | $293,731 |
| 2019 | 332 | 1,863 | 69 | 1.14 | $253,146 | $127,561 |
| 2018 | 230 | 824 | 72 | 1.30 | $170,679 | $27,822 |
| 2017 | 529 | 2,978 | 72 | 1.26 | $543,280 | $102,095 |
| 2016 | 442 | 2,248 | 72 | 1.03 | $355,225 | $68,598 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 61 | $39,710 | $104 |
| Short return visit (20+ min) | 306 | $29,102 | $69 |
| Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | 16 | $22,068 | $117 |
| Return visit (30+ min) | 93 | $11,619 | $98 |
| Destruction of skin growth, 1-14 growths | 111 | $11,549 | $92 |
| Destruction of precancer skin growth, 1 growth | 155 | $8,541 | $42 |
| Biopsy of related skin growth, first growth | 86 | $7,398 | $78 |
| New patient visit (30+ min) | 69 | $5,829 | $84 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 14 | $5,023 | None |
| Destruction of precancer skin growth, 2-14 growths | 122 | $4,213 | $6 |
| Application of light by qualified health care professional to destroy precancer skin growth | 14 | $3,543 | $208 |
| Destruction of precancer skin growth, 15 or more growths | 23 | $3,348 | $139 |
| Punch biopsy, first skin growth | 24 | $2,726 | $109 |
| Biopsy of related skin growth, each additional growth | 31 | $2,490 | $44 |
| New patient visit (45+ min) | 11 | $1,536 | $140 |
| Injection into skin growth, more than 7 growths | 14 | $1,302 | $57 |
| Injection into skin growth, 1-7 growths | 16 | $1,000 | $42 |
| Short return visit | 11 | $438 | $40 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 31 | $75 | None |
2022: 19 services
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 59 | $41,619 | $100 |
| Short return visit (20+ min) | 366 | $34,292 | $67 |
| Return visit (30+ min) | 190 | $25,372 | $92 |
| Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | 14 | $23,864 | $135 |
| Destruction of skin growth, 1-14 growths | 154 | $16,631 | $88 |
| Destruction of precancer skin growth, 1 growth | 229 | $11,605 | $41 |
| New patient visit (30+ min) | 152 | $10,710 | $70 |
| Biopsy of related skin growth, first growth | 140 | $10,707 | $70 |
| New patient visit (45+ min) | 86 | $9,028 | $105 |
| Punch biopsy, first skin growth | 75 | $7,832 | $100 |
| Destruction of precancer skin growth, 15 or more growths | 46 | $7,145 | $140 |
| Destruction of precancer skin growth, 2-14 growths | 170 | $5,380 | $6 |
| Biopsy of related skin growth, each additional growth | 58 | $3,848 | $44 |
| Injection into skin growth, 1-7 growths | 28 | $1,382 | $42 |
| Injection into skin growth, more than 7 growths | 15 | $1,053 | $53 |
| Punch biopsy, each additional skin growth | 14 | $936 | $52 |
| Short return visit | 16 | $710 | $42 |
| Injection of drug or substance under skin or into muscle | 13 | $159 | $9 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 53 | $150 | None |
2021: 22 services
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 72 | $89,914 | $106 |
| Short return visit (20+ min) | 403 | $37,860 | $67 |
| Return visit (30+ min) | 243 | $30,536 | $95 |
| Treatment of inflammatory skin disease using laser, 250.0-500.0 sq cm | 17 | $25,511 | $155 |
| Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | 21 | $20,936 | $142 |
| Destruction of skin growth, 1-14 growths | 159 | $18,287 | $90 |
| New patient visit (45+ min) | 122 | $13,711 | $112 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 22 | $12,183 | None |
| Biopsy of related skin growth, first growth | 146 | $12,087 | $78 |
| Destruction of precancer skin growth, 1 growth | 232 | $11,916 | $40 |
| New patient visit (30+ min) | 116 | $8,841 | $76 |
| Application of light by qualified health care professional to destroy precancer skin growth | 22 | $8,059 | $207 |
| Punch biopsy, first skin growth | 73 | $7,921 | $107 |
| Destruction of precancer skin growth, 15 or more growths | 35 | $5,981 | $130 |
| Destruction of precancer skin growth, 2-14 growths | 171 | $5,394 | $6 |
| Biopsy of related skin growth, each additional growth | 62 | $3,987 | $46 |
| Injection into skin growth, 1-7 growths | 29 | $1,424 | $40 |
| Injection into skin growth, more than 7 growths | 16 | $1,011 | $48 |
| Short return visit | 21 | $917 | $42 |
| Punch biopsy, each additional skin growth | 15 | $909 | $53 |
| Injection of drug or substance under skin or into muscle | 22 | $293 | $11 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 61 | $233 | None |
2020: 22 services
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 59 | $88,086 | $101 |
| Short return visit (20+ min) | 469 | $45,348 | $56 |
| New patient visit (30+ min) | 327 | $22,967 | $70 |
| Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | 25 | $16,337 | $141 |
| Biopsy of related skin growth, first growth | 163 | $13,836 | $76 |
| Destruction of precancer skin growth, 1 growth | 237 | $13,121 | $40 |
| Destruction of skin growth, 1-14 growths | 120 | $13,013 | $87 |
| Treatment of inflammatory skin disease using laser, 250.0-500.0 sq cm | 17 | $12,997 | $155 |
| Punch biopsy, first skin growth | 119 | $12,496 | $98 |
| Return visit (30+ min) | 90 | $10,063 | $81 |
| Destruction of precancer skin growth, 15 or more growths | 36 | $7,472 | $131 |
| Biopsy of related skin growth, each additional growth | 90 | $7,034 | $46 |
| Destruction of precancer skin growth, 2-14 growths | 195 | $6,738 | $5 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 14 | $5,370 | None |
| Application of light by qualified health care professional to destroy precancer skin growth | 13 | $2,689 | $179 |
| Short return visit | 47 | $1,836 | $37 |
| Injection into skin growth, more than 7 growths | 22 | $1,762 | $45 |
| Punch biopsy, each additional skin growth | 25 | $1,742 | $53 |
| Injection into skin growth, 1-7 growths | 21 | $1,170 | $43 |
| New patient visit (45+ min) | 12 | $1,125 | $94 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 56 | $268 | None |
| Injection of drug or substance under skin or into muscle | 16 | $195 | $10 |
2019: 14 services
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 40 | $49,958 | $102 |
| Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | 12 | $17,707 | $143 |
| Short return visit (20+ min) | 161 | $13,217 | $60 |
| New patient visit (30+ min) | 149 | $12,882 | $86 |
| Return visit (30+ min) | 72 | $7,439 | $89 |
| Destruction of skin growth, 1-14 growths | 49 | $5,837 | $91 |
| Biopsy of related skin growth, first growth | 49 | $4,271 | $79 |
| Destruction of precancer skin growth, 1 growth | 84 | $3,740 | $41 |
| Punch biopsy, first skin growth | 31 | $3,276 | $106 |
| Destruction of precancer skin growth, 2-14 growths | 59 | $1,680 | $5 |
| Destruction of precancer skin growth, 15 or more growths | 13 | $1,634 | $126 |
| Biopsy of related skin growth, each additional growth | 22 | $1,242 | $46 |
| Injection into skin growth, more than 7 growths | 11 | $757 | $47 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 20 | $96 | None |
2018: 8 services
| Return visit (30+ min) | 123 | $8,040 | $59 |
| Destruction of skin growth, 1-14 growths | 43 | $3,195 | $64 |
| New patient visit (30+ min) | 39 | $3,091 | $79 |
| Destruction of precancer skin growth, 1 growth | 90 | $2,966 | $32 |
| Biopsy of single growth of skin and/or tissue | 49 | $2,934 | $60 |
| New patient visit (45+ min) | 11 | $1,193 | $108 |
| Short return visit (20+ min) | 24 | $904 | $36 |
| Destruction of precancer skin growth, 2-14 growths | 77 | $866 | $3 |
2017: 15 services
| Return visit (30+ min) | 272 | $25,601 | $70 |
| Destruction of skin growth, 1-14 growths | 121 | $12,153 | $79 |
| New patient visit (30+ min) | 154 | $11,344 | $74 |
| Destruction of precancer skin growth, 1 growth | 224 | $10,163 | $36 |
| Biopsy of single growth of skin and/or tissue | 143 | $9,384 | $61 |
| Short return visit (20+ min) | 113 | $5,876 | $47 |
| Destruction of precancer skin growth, 2-14 growths | 187 | $5,060 | $4 |
| New patient visit (45+ min) | 31 | $3,932 | $127 |
| Long return visit (40+ min) | 33 | $3,748 | $94 |
| Destruction of precancer skin growth, 15 or more growths | 26 | $3,652 | $101 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 15 | $2,028 | $113 |
| Biopsy of each additional growth of skin and/or tissue | 41 | $1,376 | $25 |
| New patient visit (15+ min) | 20 | $1,010 | $50 |
| Injection into skin growth, 1-7 growths | 15 | $488 | $29 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $17 | None |
2016: 10 services
| Return visit (30+ min) | 158 | $13,867 | $69 |
| New patient visit (30+ min) | 159 | $11,786 | $74 |
| Destruction of precancer skin growth, 1 growth | 196 | $8,592 | $40 |
| Biopsy of single growth of skin and/or tissue | 110 | $6,365 | $57 |
| Destruction of skin growth, 1-14 growths | 77 | $5,821 | $68 |
| Short return visit (20+ min) | 103 | $5,288 | $47 |
| Destruction of precancer skin growth, 2-14 growths | 172 | $4,176 | $4 |
| Long return visit (40+ min) | 11 | $1,981 | $86 |
| New patient visit (15+ min) | 38 | $1,778 | $47 |
| Biopsy of each additional growth of skin and/or tissue | 28 | $932 | $21 |
Medicaid work
$92,769 in 2024
Medicaid paid $92,769 for 3,322 billed services this clinician did in 2024, up to 85 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Photochemotherapy; tar and ultraviolet B (Goeckerman treatment) or petrolatum and ultraviolet B | 1,461 | $18,861 |
| Excimer laser treatment for psoriasis; total area less than 250 sq cm | 461 | $18,509 |
| New patient visit (45+ min) | 169 | $13,424 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 149 | $12,363 |
| New patient visit (30+ min) | 264 | $11,974 |
| Return visit (30+ min) | 303 | $6,650 |
| Short return visit (20+ min) | 392 | $5,633 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 41 | $3,510 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 27 | $1,339 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion) | 13 | $275 |
| Short return visit | 27 | $199 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $31 |
| 2024 | 3,322 | 12 | 85 | $92,769 |
| 2023 | 3,460 | 13 | 86 | $83,204 |
| 2022 | 5,514 | 17 | 129 | $175,797 |
| 2021 | 9,567 | 20 | 171 | $309,980 |
| 2020 | 10,317 | 21 | 243 | $339,994 |
| 2019 | 2,052 | 11 | 79 | $94,921 |
| 2018 | 191 | 4 | 32 | $335 |
See the largest Medicaid services in earlier years
2023
| Excimer laser treatment for psoriasis; total area less than 250 sq cm | 545 | $19,404 |
| Photochemotherapy; tar and ultraviolet B (Goeckerman treatment) or petrolatum and ultraviolet B | 1,323 | $18,377 |
| Short return visit (20+ min) | 631 | $15,437 |
| Return visit (30+ min) | 382 | $11,997 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 114 | $5,549 |
| New patient visit (30+ min) | 117 | $5,405 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 67 | $3,153 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 68 | $1,918 |
| New patient visit (45+ min) | 27 | $855 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion) | 31 | $561 |
| Injection, intralesional; more than 7 lesions | 27 | $363 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 113 | $113 |
2022
| Return visit (30+ min) | 925 | $32,127 |
| Short return visit (20+ min) | 844 | $26,920 |
| New patient visit (45+ min) | 375 | $26,276 |
| New patient visit (30+ min) | 405 | $20,766 |
| Excimer laser treatment for psoriasis; total area less than 250 sq cm | 432 | $16,302 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 301 | $15,614 |
| Photochemotherapy; tar and ultraviolet B (Goeckerman treatment) or petrolatum and ultraviolet B | 1,144 | $12,257 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 218 | $9,804 |
| Punch biopsy of skin (including simple closure, when performed); single lesion | 136 | $7,502 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 149 | $3,958 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion) | 92 | $1,054 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); each separate/additional lesion (List separately in addition to code for primary procedure) | 34 | $868 |
2021
| Excimer laser treatment for psoriasis; total area less than 250 sq cm | 897 | $52,981 |
| Return visit (30+ min) | 1,351 | $52,809 |
| New patient visit (45+ min) | 723 | $43,498 |
| Short return visit (20+ min) | 1,315 | $38,958 |
| Photochemotherapy; tar and ultraviolet B (Goeckerman treatment) or petrolatum and ultraviolet B | 1,945 | $25,954 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 506 | $19,927 |
| New patient visit (30+ min) | 470 | $19,891 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 372 | $14,763 |
| Punch biopsy of skin (including simple closure, when performed); single lesion | 246 | $12,561 |
| Excimer laser treatment for psoriasis; 250 sq cm to 500 sq cm | 278 | $11,318 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 285 | $6,331 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); each separate/additional lesion (List separately in addition to code for primary procedure) | 87 | $3,881 |
2020
| New patient visit (30+ min) | 1,534 | $70,093 |
| Short return visit (20+ min) | 2,347 | $69,526 |
| Excimer laser treatment for psoriasis; total area less than 250 sq cm | 630 | $40,131 |
| Return visit (30+ min) | 596 | $30,246 |
| Photochemotherapy; tar and ultraviolet B (Goeckerman treatment) or petrolatum and ultraviolet B | 1,951 | $27,811 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 501 | $24,608 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 470 | $23,526 |
| Punch biopsy of skin (including simple closure, when performed); single lesion | 386 | $20,932 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); each separate/additional lesion (List separately in addition to code for primary procedure) | 255 | $9,700 |
| Excimer laser treatment for psoriasis; 250 sq cm to 500 sq cm | 72 | $5,861 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 279 | $5,743 |
| Short return visit | 200 | $3,041 |
2019
| New patient visit (30+ min) | 397 | $29,501 |
| Return visit (30+ min) | 274 | $17,756 |
| Short return visit (20+ min) | 508 | $15,323 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 117 | $11,951 |
| Photochemotherapy; tar and ultraviolet B (Goeckerman treatment) or petrolatum and ultraviolet B | 490 | $11,117 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 62 | $4,482 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 75 | $3,341 |
| Punch biopsy of skin (including simple closure, when performed); single lesion | 13 | $683 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 63 | $327 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion) | 12 | $263 |
| URINE PREGNANCY TEST | 41 | $175 |
2018
| New patient visit (30+ min) | 16 | $335 |
| Photochemotherapy; tar and ultraviolet B (Goeckerman treatment) or petrolatum and ultraviolet B | 27 | $0 |
| Short return visit (20+ min) | 116 | $0 |
| Return visit (30+ min) | 32 | $0 |
Drugs they prescribed that Part D paid
$545,751
Pharmacies billed $545,751 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,132) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
1,031 generic and fewer than 11 brand-name prescriptions · $545,751 in drug cost · 64 antibiotic prescriptions to 27 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 19 | $131,926 | $6,943 |
| Dupixent | 26 | $116,440 | $4,478 |
| Otezla | 20 | $97,695 | $4,885 |
| Clobetasol Propionate | 166 | $5,991 | $36 |
| Ketoconazole | 189 | $2,768 | $15 |
See all 20 drugs
| Dupixent | 19 | $131,926 | $6,943 |
| Dupixent | 26 | $116,440 | $4,478 |
| Otezla | 20 | $97,695 | $4,885 |
| Clobetasol Propionate | 166 | $5,991 | $36 |
| Ketoconazole | 189 | $2,768 | $15 |
| Doxycycline Monohydrate | 51 | $2,733 | $54 |
| Betamethasone Dipropionate | 43 | $1,823 | $42 |
| Fluorouracil | 27 | $1,561 | $58 |
| Clindamycin Phosphate | 77 | $960 | $12 |
| Mycophenolate Mofetil | 12 | $861 | $72 |
| Triamcinolone Acetonide | 77 | $713 | $9 |
| Fluocinonide | 23 | $704 | $31 |
| Spironolactone | 36 | $666 | $19 |
| Minoxidil | 55 | $547 | $10 |
| Prednisone | 18 | $351 | $19 |
| Valacyclovir | 11 | $282 | $26 |
| Hydrocortisone | 65 | $241 | $4 |
| Gabapentin | 20 | $234 | $12 |
| Mupirocin | 25 | $177 | $7 |
| Terbinafine | 11 | $138 | $13 |
Year by year
| 2024 | 1,132 | 276 | 0% (0) | None | $545,751 |
| 2023 | 995 | 232 | 0% (0) | 9% | $471,821 |
| 2022 | 1,024 | 214 | 0% (0) | 11% | $418,228 |
| 2021 | 799 | 235 | None | 11% | $123,782 |
| 2020 | 868 | 265 | 0% (0) | 14% | $185,854 |
| 2019 | 962 | 283 | 0% (0) | 10% | $137,972 |
| 2018 | 578 | 213 | None | 10% | $91,588 |
| 2017 | 541 | 181 | 0% (0) | 16% | $135,391 |
| 2016 | 416 | 167 | 0% (0) | 13% | $49,067 |
| 2015 | 118 | 53 | 0% (0) | 19% | $21,133 |
| 2014 | 136 | 56 | None | None | $23,428 |
| 2013 | 252 | 72 | 0% (0) | None | $39,758 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Humira(Cf) | 13 | $97,194 | $7,476 |
| Dupixent | 15 | $62,206 | $4,147 |
| Otezla | 12 | $54,737 | $4,561 |
| Clobetasol Propionate | 175 | $13,372 | $76 |
| Doxycycline Monohydrate | 78 | $4,957 | $64 |
| Fluorouracil | 29 | $2,955 | $102 |
| Betamethasone Dipropionate | 35 | $2,859 | $82 |
| Ketoconazole | 144 | $2,667 | $19 |
| Clindamycin Phosphate | 66 | $1,479 | $22 |
| Mycophenolate Mofetil | 13 | $1,407 | $108 |
| Triamcinolone Acetonide | 86 | $1,352 | $16 |
| Tretinoin | 12 | $1,350 | $112 |
| Fluocinonide | 11 | $1,193 | $108 |
| Spironolactone | 21 | $793 | $38 |
| Methotrexate | 15 | $514 | $34 |
| Prednisone | 16 | $375 | $23 |
| Hydrocortisone | 46 | $310 | $7 |
| Hydroxyzine | 17 | $293 | $17 |
| Mupirocin | 12 | $176 | $15 |
| Minoxidil | 23 | $166 | $7 |
2022: 19 drugs
| Cosentyx Pen (2 Pens) | 20 | $183,352 | $9,168 |
| Humira(Cf) | 12 | $81,630 | $6,802 |
| Dupixent | 12 | $45,703 | $3,809 |
| Clobetasol Propionate | 175 | $18,608 | $106 |
| Betamethasone Dipropionate | 43 | $3,705 | $86 |
| Ketoconazole | 158 | $3,555 | $23 |
| Betamethasone Diprop Augmented | 19 | $2,979 | $157 |
| Doxycycline Monohydrate | 76 | $2,799 | $37 |
| Fluorouracil | 27 | $2,487 | $92 |
| Clindamycin Phosphate | 68 | $1,952 | $29 |
| Fluocinonide | 17 | $1,898 | $112 |
| Tretinoin | 13 | $1,532 | $118 |
| Metronidazole | 16 | $992 | $62 |
| Nystop | 14 | $951 | $68 |
| Triamcinolone Acetonide | 77 | $731 | $9 |
| Spironolactone | 19 | $547 | $29 |
| Hydrocortisone | 56 | $300 | $5 |
| Prednisone | 23 | $224 | $10 |
| Minoxidil | 11 | $124 | $11 |
2021: 14 drugs
| Clobetasol Propionate | 119 | $8,597 | $72 |
| Betamethasone Dipropionate | 60 | $5,573 | $93 |
| Calcipotriene | 21 | $2,846 | $136 |
| Ketoconazole | 116 | $2,828 | $24 |
| Fluorouracil | 25 | $2,383 | $95 |
| Doxycycline Monohydrate | 72 | $2,379 | $33 |
| Betamethasone Diprop Augmented | 18 | $1,953 | $109 |
| Metronidazole | 12 | $1,044 | $87 |
| Triamcinolone Acetonide | 72 | $980 | $14 |
| Clindamycin Phosphate | 25 | $956 | $38 |
| Spironolactone | 23 | $560 | $24 |
| Hydrocortisone | 50 | $319 | $6 |
| Terbinafine | 11 | $84 | $8 |
| Mupirocin | 11 | $74 | $7 |
2020: 14 drugs
| Dupixent | 14 | $45,926 | $3,280 |
| Clobetasol Propionate | 127 | $8,628 | $68 |
| Betamethasone Dipropionate | 76 | $7,798 | $103 |
| Clindamycin Phosphate | 25 | $4,135 | $165 |
| Betamethasone Diprop Augmented | 24 | $3,956 | $165 |
| Halobetasol Propionate | 24 | $3,024 | $126 |
| Fluorouracil | 28 | $3,009 | $107 |
| Doxycycline Monohydrate | 85 | $2,747 | $32 |
| Ketoconazole | 127 | $2,432 | $19 |
| Fluocinonide | 25 | $2,174 | $87 |
| Triamcinolone Acetonide | 63 | $799 | $13 |
| Doxycycline Hyclate | 11 | $480 | $44 |
| Hydrocortisone | 49 | $247 | $5 |
| Mupirocin | 22 | $178 | $8 |
2019: 16 drugs
| Clobetasol Propionate | 178 | $19,615 | $110 |
| Halobetasol Propionate | 36 | $5,812 | $161 |
| Fluocinonide | 50 | $3,143 | $63 |
| Betamethasone Dipropionate | 25 | $2,977 | $119 |
| Calcipotriene | 14 | $2,737 | $196 |
| Ketoconazole | 123 | $2,696 | $22 |
| Clindamycin Phosphate | 61 | $2,555 | $42 |
| Betamethasone Diprop Augmented | 26 | $2,458 | $95 |
| Fluorouracil | 15 | $1,963 | $131 |
| Doxycycline Monohydrate | 48 | $1,692 | $35 |
| Triamcinolone Acetonide | 90 | $1,446 | $16 |
| Hydrocortisone | 56 | $282 | $5 |
| Doxycycline Hyclate | 14 | $253 | $18 |
| Gabapentin | 13 | $137 | $11 |
| Spironolactone | 13 | $92 | $7 |
| Prednisone | 12 | $75 | $6 |
2018: 12 drugs
| Clobetasol Propionate | 171 | $26,352 | $154 |
| Fluocinolone Acetonide | 14 | $2,085 | $149 |
| Fluorouracil | 15 | $1,650 | $110 |
| Ketoconazole | 57 | $1,327 | $23 |
| Clindamycin Phosphate | 19 | $1,313 | $69 |
| Fluocinonide | 15 | $1,169 | $78 |
| Doxycycline Hyclate | 21 | $1,013 | $48 |
| Triamcinolone Acetonide | 51 | $915 | $18 |
| Metronidazole | 11 | $655 | $60 |
| Doxycycline Monohydrate | 17 | $372 | $22 |
| Hydrocortisone | 39 | $219 | $6 |
| Mupirocin | 15 | $199 | $13 |
2017: 11 drugs
| Clobetasol Propionate | 117 | $22,017 | $188 |
| Fluorouracil | 30 | $3,634 | $121 |
| Metronidazole | 15 | $2,410 | $161 |
| Fluocinolone Acetonide | 11 | $2,212 | $201 |
| Doxycycline Hyclate | 37 | $1,940 | $52 |
| Clindamycin Phosphate | 23 | $1,167 | $51 |
| Ketoconazole | 29 | $865 | $30 |
| Fluocinonide | 11 | $819 | $74 |
| Triamcinolone Acetonide | 54 | $694 | $13 |
| Spironolactone | 20 | $230 | $12 |
| Hydrocortisone | 22 | $114 | $5 |
2016: 9 drugs
| Clobetasol Propionate | 91 | $16,370 | $180 |
| Fluorouracil | 20 | $3,383 | $169 |
| Fluocinonide | 16 | $1,530 | $96 |
| Ketoconazole | 41 | $1,359 | $33 |
| Doxycycline Hyclate | 11 | $915 | $83 |
| Triamcinolone Acetonide | 45 | $631 | $14 |
| Clindamycin Phosphate | 11 | $497 | $45 |
| Doxycycline Monohydrate | 14 | $364 | $26 |
| Hydrocortisone | 37 | $203 | $5 |
2015: 3 drugs
| Clobetasol Propionate | 32 | $7,806 | $244 |
| Doxycycline Monohydrate | 13 | $393 | $30 |
| Triamcinolone Acetonide | 11 | $93 | $8 |
2014: 2 drugs
| Clobetasol Propionate | 23 | $2,271 | $99 |
| Desonide | 13 | $2,052 | $158 |
2013: 6 drugs
| Fluocinonide | 21 | $1,126 | $54 |
| Minocycline | 18 | $1,109 | $62 |
| Clindamycin Phosphate | 14 | $783 | $56 |
| Clobetasol Propionate | 17 | $529 | $31 |
| Tretinoin | 11 | $347 | $32 |
| Triamcinolone Acetonide | 13 | $181 | $14 |
Money from drug and device companies
$799 in 2025
| 2025 | 9 | 52 | None | $799 |
| 2024 | 10 | 51 | None | $857 |
| 2023 | 9 | 35 | $800 | $2,830 |
| 2022 | 5 | 11 | None | $208 |
| 2021 | 5 | 7 | None | $104 |
| 2020 | 2 | 2 | None | $134 |
| 2019 | 10 | 18 | None | $473 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Galderma Laboratories L.P. | None | $280 | 21 payments
|
| Novartis Pharmaceuticals | Cosentyx | $234 | 16 payments
|
| Abbvie | Skyrizi | $90 | 5 payments
|
| Incyte | Opzelura | $71 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $48 | 3 payments
|
| LEO Pharma | Adbry | $33 | 1 payment
|
See all 52 published payments
| Novartis Pharmaceuticals | Meals · 2025-12-23 | Cosentyx | $22 |
| Galderma Laboratories L.P. | Meals · 2025-12-19 | None | $19 |
| Galderma Laboratories L.P. | Meals · 2025-12-09 | None | $12 |
| Novartis Pharmaceuticals | Meals · 2025-11-18 | Cosentyx | $16 |
| Galderma Laboratories L.P. | Meals · 2025-11-08 | None | $8 |
| Ucb | Meals · 2025-11-06 | Bimzelx | $21 |
| Abbvie | Meals · 2025-10-30 | Skyrizi | $17 |
| Novartis Pharmaceuticals | Meals · 2025-10-16 | Cosentyx | $20 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-07 | Sotyktu | $15 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-10 | Sotyktu | $20 |
| Galderma Laboratories L.P. | Meals · 2025-09-10 | None | $14 |
| Novartis Pharmaceuticals | Meals · 2025-09-04 | Cosentyx | $16 |
| Novartis Pharmaceuticals | Meals · 2025-09-04 | Cosentyx | $16 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-28 | Sotyktu | $14 |
| Galderma Laboratories L.P. | Meals · 2025-08-21 | None | $9 |
| Novartis Pharmaceuticals | Meals · 2025-08-20 | Cosentyx | $15 |
| Novartis Pharmaceuticals | Meals · 2025-08-20 | Cosentyx | $15 |
| Amgen | Meals · 2025-08-14 | Otezla | $21 |
| Novartis Pharmaceuticals | Meals · 2025-08-08 | Cosentyx | $17 |
| Galderma Laboratories L.P. | Meals · 2025-07-31 | None | $20 |
| Novartis Pharmaceuticals | Meals · 2025-07-28 | Cosentyx | $12 |
| Incyte | Meals · 2025-07-23 | Opzelura | $27 |
| Galderma Laboratories L.P. | Meals · 2025-07-18 | None | $20 |
| Galderma Laboratories L.P. | Meals · 2025-07-18 | None | $5 |
| Novartis Pharmaceuticals | Meals · 2025-07-02 | Cosentyx | $4 |
| Novartis Pharmaceuticals | Meals · 2025-07-02 | Cosentyx | $2 |
| Novartis Pharmaceuticals | Meals · 2025-06-25 | Cosentyx | $14 |
| Abbvie | Meals · 2025-06-25 | Botox | $14 |
| Incyte | Meals · 2025-06-24 | Opzelura | $29 |
| Galderma Laboratories L.P. | Meals · 2025-06-11 | None | $13 |
| Galderma Laboratories L.P. | Meals · 2025-06-04 | None | $19 |
| LEO Pharma | Meals · 2025-05-22 | Adbry | $33 |
| Novartis Pharmaceuticals | Meals · 2025-05-21 | Cosentyx | $19 |
| Galderma Laboratories L.P. | Meals · 2025-05-17 | None | $16 |
| Novartis Pharmaceuticals | Meals · 2025-05-14 | Cosentyx | $16 |
| Abbvie | Meals · 2025-04-15 | Skyrizi | $16 |
| Galderma Laboratories L.P. | Meals · 2025-04-05 | None | $15 |
| Abbvie | Meals · 2025-04-01 | Rinvoq | $28 |
| Novartis Pharmaceuticals | Meals · 2025-03-27 | Cosentyx | $16 |
| Galderma Laboratories L.P. | Meals · 2025-03-07 | None | $6 |
| Galderma Laboratories L.P. | Meals · 2025-03-05 | None | $15 |
| Galderma Laboratories L.P. | Meals · 2025-02-21 | None | $10 |
| Incyte | Meals · 2025-02-15 | Opzelura | $15 |
| Galderma Laboratories L.P. | Meals · 2025-02-13 | None | $9 |
| Novartis Pharmaceuticals | Meals · 2025-02-06 | Cosentyx | $14 |
| Organon | Meals · 2025-02-06 | Vtama | $2 |
| Galderma Laboratories L.P. | Meals · 2025-02-02 | None | $9 |
| Galderma Laboratories L.P. | Meals · 2025-01-28 | None | $15 |
| Galderma Laboratories L.P. | Meals · 2025-01-25 | None | $11 |
| Galderma Laboratories L.P. | Meals · 2025-01-25 | None | $20 |
| Galderma Laboratories L.P. | Meals · 2025-01-24 | None | $13 |
| Abbvie | Meals · 2025-01-15 | Skyrizi | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $857
| Galderma Laboratories L.P. | None | $286 | 21 payments
|
| Abbvie | Botox | $240 | 14 payments
|
| Novartis Pharmaceuticals | Cosentyx | $132 | 7 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $62 | 3 payments
|
| Incyte | Opzelura | $30 | 1 payment
|
| Krystal Biotech | Vyjuvek | $28 | 1 payment
|
| LEO Pharma | Adbry | $21 | 1 payment
|
| Ucb | Bimzelx | $20 | 1 payment
|
| Amgen | Otezla | $19 | 1 payment
|
| Dermavant Sciences | Vtama | $19 | 1 payment
|
2023: $2,830
| Merz North America | Xeomin | $1,565 | 10 payments
|
| AbbVie | Skyrizi | $842 | 3 payments
|
| Novartis Pharmaceuticals | Cosentyx | $232 | 12 payments
|
| LEO Pharma | Adbry | $55 | 3 payments
|
| Genzyme | Dupixent | $33 | 1 payment
|
| Galderma Laboratories L.P. | None | $32 | 2 payments
|
| Dermavant Sciences | Vtama | $30 | 2 payments
|
| Pfizer | Eucrisa | $26 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $17 | 1 payment
|
2022: $208
| Allergan | Botox | $62 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $44 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $44 | 3 payments
|
| Incyte | Opzelura | $43 | 2 payments
|
| Abbvie | Skyrizi | $15 | 1 payment
|
2021: $104
| Allergan | Botox | $30 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $25 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $23 | 1 payment
|
| Sun Pharmaceutical Industries | Absorica Ld | $14 | 1 payment
|
| AbbVie | Skyrizi | $12 | 1 payment
|
2020: $134
| LEO Pharma | None | $123 | 1 payment
|
| AbbVie | Skyrizi | $11 | 1 payment
|
2019: $473
| Celgene | Otezla | $82 | 2 payments
|
| Galderma Laboratories L.P. | None | $73 | 1 payment
|
| AbbVie | Humira | $69 | 4 payments
|
| Amgen | Enbrel | $61 | 3 payments
|
| Ucb | Cimzia | $50 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $49 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $28 | 1 payment
|
| Janssen Biotech | Tremfya | $26 | 1 payment
|
| DUSA Pharmaceuticals | Levulan Kerastick | $18 | 1 payment
|
| Merz North America | None | $17 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 84.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1518278357
- Licence
- CA A122534California A122534: Current · expires 2028-06-30
- Trained
- University of California, Davis School of Medicine, 2011 · 15 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 1495 River Park Dr Ste 200, Sacramento, CA, 95815
- NPI first listed
- 2010-06-26
- NPI last updated
- 2025-10-21
- NPI record certified
- 2025-10-21
This is when the NPI record was last certified, not a medical board exam.